Researchers designed SAMiRNAs targeting mouse Areg mRNA (SAMiRNA-mAREG) and, in this experimental model, after inoculation into the target organs, the SAMiRNAs achieved the targeted inhibition of AREG synthesis and a consequent decrease in all parameters associated with pulmonary and renal fibrosis [50]. This evidence concerns the gene AREG and renal fibrosis.